A timeline of symptom onset and disease progression in CLN3 disease
Ineka T. Whiteman(EnergyAustralia (Australia)), Heather Adams(University of Rochester Medicine), Alexandra Johnson(Sydney Children's Hospital), John R. Østergaard(Aarhus University Hospital), Jonathan W. Mink(Science Take-Out (United States)), Jennifer Vermilion(University of Rochester Medicine), Amy Vierhile(University of Rochester Medicine), Erika F. Augustine(University of Rochester Medical Center), Heather Mason(Shared Services Canada), Aidan Bindoff(University of Tasmania), Angela Schulz(Universität Hamburg), Anthony L. Cook(University of Tasmania)
Cited by 3
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Airborne High Spectral Resolution Lidar for profiling aerosol optical properties
|Applied Optics|2008|694
Single-cell eQTL mapping identifies cell type–specific genetic control of autoimmune disease
|Science|2022|691
Aerosol classification using airborne High Spectral Resolution Lidar measurements – methodology and examples
|Atmospheric measurement techniques|2012|648
Mind the Gap: Are students prepared for higher education?
|Journal of Further and Higher Education|2003|580